Skip to main content
Caplight Logo









Ailurus Biotechnology

Ailurus Biotechnology

Private
LondonHealthcare & Life Scienceshttps://ailurus.bio/

Last Round

Angel

Oct 27, 2021

Total Funding Raised

$3.1M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Ailurus Biotechnology is a synthetic biology company that develops biocomputing platforms and automated workflows to streamline protein engineering and scientific discovery.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Biotech Equipment, Workflow Automation, Medical AI

Business Model

B2B

Customer Profile

Services & Consulting, Usage-Based SaaS

AI Layer

Application

Keywords

synthetic biologybiocomputingprotein engineeringbiofoundryautomated biologymetabolic pathway engineeringprotein purificationsynthetic organellesbioprogramminghigh-throughput screeninglab automationAI-driven drug discoverybiotech R&D servicesbioengineering

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Ailurus Biotechnology Comparables

Compare Ailurus Biotechnology with similar companies based on industry and business-model similarity.

Ailurus Biotechnology comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Adaptyv Bio
83%
BigHat Biosciences
77%
Liberum Biotech
75%

Ailurus Biotechnology Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AngelOct 27, 2021
AcceleratorOct 12, 2020

Key People

Founding team and executive leadership

Haotian Guo

Founder & CEO

Founding Team

Ailurus Biotechnology Investors

Notable investors and investment history

Ailurus Biotechnology investors
InvestorRounds
GeniLink CapitalAngel
5Y CapitalAngel
MiraclePlusAccelerator, Angel

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 24, 2026

    Monthly visitors grew 36% MoM, reaching 5.2K.

  • Jan 20, 2026

    Monthly visitors increased 48% MoM.

Ailurus Biotechnology Filings

Explore SEC and related filing metadata, where available.

Ailurus Biotechnology filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Ailurus Biotechnology's valuation, stock price, and market status.

Is Ailurus Biotechnology a public or private company?

Ailurus Biotechnology is a private company.

What is the current stock price of Ailurus Biotechnology?

Ailurus Biotechnology is a private company with no public stock price. No recent secondary market data is available.

How much is Ailurus Biotechnology worth (valuation)?

Valuation information for Ailurus Biotechnology is not publicly available.

Can I buy Ailurus Biotechnology stock?

Ailurus Biotechnology shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Ailurus Biotechnology's last funding round?

Ailurus Biotechnology's most recent funding round was Angel on October 27, 2021.

Who are the main investors in Ailurus Biotechnology?

Key investors in Ailurus Biotechnology include GeniLink Capital.

Will Ailurus Biotechnology IPO soon?

No public IPO plans have been announced for Ailurus Biotechnology.

How can I track Ailurus Biotechnology secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Ailurus Biotechnology's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersLondon
Employee Range17
Year Founded2022
Last FundingOct 27, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?